Atlanta News Online

Bipolar disorder Market: Epidemiological analysis, Current treatment landscape and emerging therapies

 Breaking News
  • No posts were found

Bipolar disorder Market: Epidemiological analysis, Current treatment landscape and emerging therapies

March 26
16:54 2020
Bipolar disorder Market: Epidemiological analysis, Current treatment landscape and emerging therapies

Bipolar disorder Market
DelveInsight’s “Bipolar Disorder Market Insights and Forecast Report” delivers an in-depth understanding of the Bipolar Disorder, historical and forecasted epidemiology as well as the Bipolar Disorder market trends, pipeline scenario, Bipolar disorder market drivers, barriers, and forecasted analysis in the 7MM for the study period 2017-30.

 

Bipolar Disorder (Manic depression) is categorized by recurrent-shifts in the mood/temper and is a manic-depressive disorder hindering the routine life of an individual.

The American Psychiatric Association categorizes Bipolar disorder into four major types of bipolar disorder: Bipolar I disorder, Bipolar II disorder, Cyclothymic disorder, and Bipolar disorder due to another medical or substance abuse disorder.

Bipolar disorder affects about 45 million people worldwide, says WHO.

 

DelveInsight’s ‘Bipolar disorder Market Insight and Forecast – 2030’ report delivers an in-depth understanding of the Bipolar Disorder, historical and forecasted epidemiology as well as the Bipolar Disorder market trends in the 7MM (the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan, for the study period 2017-30.

The Bipolar Disorder market report proffers a complete view of epidemiological analysis – historical and forecasted, diagnosis tactics, present treatment régime, forthcoming novel therapies, and unmet needs along with drivers and barriers present in the Bipolar Disorder market.

 

Bipolar Disorder Market: Disease Understanding and Therapies available

The DelveInsight Bipolar Disorder market report gives a detailed understanding of the Bipolar Disorder by including particulars such as disease description, symptoms, causes, pathophysiology, diagnosis and treatment.

The market report offers insights into historical and 11-year forecasted Bipolar Disorder patient pool and forecasted trend for 7MM countries. It helps to identify current and forecasted Bipolar market trends by exploring numerous kinds of literature and studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool, with incidence and prevalence and their trends along with assumptions undertaken. 

The report covers a thorough view of the conventional as well as present treatment approaches for Bipolar Disorder, providing treatment algorithms and guidelines in the United States, EU5, and Japan.

 

Bipolar Disorder Market: Marketed, and Upcoming Drugs

FDA-approved agents for the acute treatment of bipolar depression include Olanzapine-fluoxetine combination, Lurasidone, and Quetiapine.

Other off-label therapies present in the Bipolar disorder market are Anticonvulsants (such as Divalproex and lamotrigine), olanzapine monotherapy, and Lithium and lamotrigine combined therapy.

The Bipolar Disorder market report covers detailed picture of marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. The report helps in providing a better understanding of clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

 

 

Request for Sample Pages.

 

Bipolar Disorder Market landscape

The Bipolar Disorder market outlook proffers a detailed comprehension of the historic, current, and forecasted Bipolar Disorder market trends by scrutinizing the impact of current therapies on the Bipolar Disorder market, unmet needs, Bipolar market drivers and barriers and demand of better expertise.

The Bipolar Disorder market report covers each marketed drug and late-stage pipeline therapy with their cost, inclusion and exclusion criteria’s, mechanism of action, therapy compliance rate, a growing need in the market, patient pool, expected launch year, competitive analysis, brand value, their impact on the market and view of the key opinion leaders.

Key Companies and Drugs driving Bipolar disorder market forward are Lundbeck and Otsuka Pharmaceutical (Brexpiprazole), Intra-Cellular Therapies (Lumateperone (ITI-007)), Sage Therapeutics (Sage-217) and several others.

According to DelveInsight, Bipolar Disorder market in 7MM is expected to shift positively in the study period 2017-2030.

 

Bipolar Disorder Report Highlights

  • Dynamic Bipolar Disorder market trends
  • Healthcare spending fuelling Bipolar Disorder Market
  • Collaborations, mergers, and acquisitions in   Market
  • Challenges poised and opportunities present influencing Bipolar Disorder Market
  • R&D driving   Market 
  • Novel therapies and drugs in Bipolar Disorder pipeline
  • Major players involved impacting Bipolar Disorder    market
  • In-depth analysis of the pipeline products (Phase III and Phase II), comparative analysis with detailed clinical profiles, key cross-competition, launch date along with product development activities

 

Know more about the report.

 

Table of Contents

1. Key Insights

2. Executive Summary of Bipolar Disorder   

3. Competitive Intelligence Analysis for Bipolar Disorder   

4. Bipolar Disorder: Market Overview at a Glance

5. Bipolar Disorder: Disease Background and Overview

6. Patient Journey

7. Bipolar Disorder Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Bipolar Disorder Treatment

11. Marketed Products

12. Emerging Therapies

13. Bipolar Disorder: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Bipolar Disorder   

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

Read more.

 

About DelveInsight

DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for

Browse through our vast repository from here.

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/


Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/atlantanewsonlin/news.atlantanews-online.com/wp-includes/functions.php on line 4469